Mukesh Ambani Will Be Entry In New Business Genome Testing With World Cheapest 12000 Rupees Kit

Mukesh Ambani News: Billionaire Mukesh Ambani’s group is now ready to strengthen its hold in another business. Reliance Industries is getting involved in genetic mapping. India’s growing consumer market is looking to make healthcare more affordable and comprehensive, led by American startups like 23&Me.

According to a Bloomberg report, Ramesh Hariharan, CEO of Strand Life Sciences Pvt, said the energy-to-ecommerce conglomerate would introduce a comprehensive Rs 12,000 ($145) genome testing within weeks. Please tell that Reliance Industries had bought a stake in Strand Life Sciences Pvt and now it has 80 percent stake.

The CEO of Strand Life said genome testing, which is about 86 per cent cheaper than other locally available offerings. They said it could be used to identify cancer, heart and neuro-degenerative diseases as well as inherited genetic diseases.

Big relief for 1.4 billion people

This project will bring affordable personal gen-mapping to India’s 1.4 billion people. It will be offered at an affordable price. The CEO of the company told that this will be the cheapest genomic profile in the world. He said that is an aggressive decision.

Mukesh Ambani’s strategy is like this

It has been said in the report that in a similar way, Mukesh Ambani took entry in the retail sector in 2006 and in the telecom sector in 2016 and reduced the prices and these prices were not increased until the company became the market leader. I did not emerge.

genetic testing market

According to a report by Allied Market Research, the global genetic testing market was valued at $12.7 billion in 2019 and is expected to reach $21.3 billion by 2027.

read this also

Layoffs: This giant car maker announced layoffs, 500 people lost their jobs, know the reason